First Multicenter Study of Modified Release Phosphatidylcholine “LT-02” in Ulcerative Colitis: A Randomized, Placebo-Controlled Trial in Mesalazine-Refractory Courses
American Journal of Gastroenterology - United States
doi 10.1038/ajg.2014.104
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2014
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)